BIO-key International, Inc.Find Ratings Reports
BIO-KEY INTERNATIONAL INC's gross profit margin for the fourth quarter of its fiscal year 2019 has significantly decreased when compared to the same period a year ago. Sales and net income fell significantly, underperforming compared to the average company in its subsector. BIO-KEY INTERNATIONAL INC has very weak liquidity. Currently, the Quick Ratio is 0.19 which clearly shows a lack of ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.
At the same time, stockholders' equity ("net worth") has significantly decreased by 121.83% from the same quarter last year. The key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY19||Q4 FY18|
|Net Sales ($mil)||0.54||1.72|
|Net Income ($mil)||-9.53||-1.38|
|Balance Sheet||Q4 FY19||Q4 FY18|
|Cash & Equiv. ($mil)||0.59||0.32|
|Total Assets ($mil)||2.5||11.69|
|Total Debt ($mil)||2.82||0.0|
|Profitability||Q4 FY19||Q4 FY18|
|Gross Profit Margin||-14.58||40.87|
|Return on Assets||-584.26||-58.74|
|Return on Equity||0.0||-81.17|
|Debt||Q4 FY19||Q4 FY18|
|Share Data||Q4 FY19||Q4 FY18|
|Shares outstanding (mil)||14.41||13.98|
|Div / share||0.0||0.0|
|Book value / share||-0.16||0.75|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||2343100.0||60582.0|
SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. Along with this, the price-to-book ratio is also meaningless due to a negative book value for the company, making any comparisons useless. The price-to-sales ratio is well above the S&P 500 average, but well below the subsector average.
|BKYI NM||Peers 103.56||BKYI NM||Peers 65.95|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
BKYI's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
BKYI's P/CF is negative making the measure meaningless.
|BKYI NM||Peers 64.09||BKYI NA||Peers 2.15|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
BKYI's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|BKYI NM||Peers 19.58||BKYI -30.76||Peers 83.31|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
BKYI's P/B is negative making this valuation measure meaningless.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, BKYI is expected to significantly trail its peers on the basis of its earnings growth rate.
|BKYI 5.33||Peers 12.15||BKYI -43.92||Peers 25.87|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
BKYI is trading at a significant discount to its subsector on this measurement.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
BKYI significantly trails its peers on the basis of sales growth.